[Federal Register Volume 66, Number 155 (Friday, August 10, 2001)]
[Notices]
[Page 42239]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-20109]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 9, 2001, Lilly Del 
Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, 
Puerto Rico 00680, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of 
dextropropoxyphene (9273), a basic class of controlled substance listed 
in Schedule II.
    The firm plans to manufacture bulk product for distribution to its 
customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substance may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than October 9, 2001.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-20109 Filed 8-9-01; 8:45 am]
BILLING CODE 4410-09-M